Targeting Caveolin-1 Deficiency in Bone Marrow Derived Cells: A New Therapeutic Window for Fibrotic Diseases?
Main Authors: | Antonio eRecchiuti, Eleonora eCianci |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00193/full |
Similar Items
-
T cell migration in rheumatoid arthritis
by: Mario eMellado, et al.
Published: (2015-07-01) -
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
by: Antonio Recchiuti, et al.
Published: (2019-04-01) -
IMMUNOLOGICAL ASPECTS OF ESSENTIAL HYPERTENSION
by: Ya. R. Timasheva
Published: (2019-07-01) -
IMMUNOLOGICAL ASPECTS OF ESSENTIAL HYPERTENSION
by: Yanina Rimovna Timasheva
Published: (2019-03-01) -
Mast Cells May Regulate The Anti-Inflammatory Activity of IL-37
by: Theoharis C. Theoharides, et al.
Published: (2019-07-01)